Impact of clozapine on completed suicide

American Journal of Psychiatry

Volumn 158, Issue 6, 2001, Pages 931-937

  Sernyak, M J ^a   Desai, R ^a   Stolar, M ^a   Rosenheck, R ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SOLDIER; STATISTICAL ANALYSIS; SUICIDE;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; CAUSE OF DEATH; CLOZAPINE; CONTINENTAL POPULATION GROUPS; DATABASES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HOSPITALS, VETERANS; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SCHIZOPHRENIA; SUICIDE; SURVIVAL ANALYSIS; VETERANS;

EID: 0034976028     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.6.931     Document Type: Article

References (36)

1. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
2. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
3. Clinical and biological response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine
4. Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns
5. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
6. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
7. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia
8. Clozapine-induced agranulocytosis: Incidence and risk factors in the United States
9. Clinical profile of clozapine: Adverse reactions and agranulocytosis
10. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment
11. Mortality in current and former users of clozapine
12. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder
13. Excess mortality in schizophrenia and affective disorders: Do suicides and accidental deaths solely account for this excess?
14. Mortality in schizophrenia - The Iowa Record-Linkage Study: A comparison with general population mortality
15. The Iowa 500: Suicide in mania, depression, and schizophrenia
16. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia
17. Suicide in chronic schizophrenia
18. Clozapine's effectiveness for patients in state hospitals: Results from a randomized trial
19. Reducing bias in observational studies using subclassification on the propensity score
20. The central role of the propensity score in observational studies for causal effects
21. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score
22. Agreement between administrative files and written medical records: A case of the Department of Veterans Affairs
23. The impact of VA reorganization on patterns of mental health care
24. Association of venous thromboembolism and clozapine
25. Suicide in schizophrenia: Risk factors and clozapine treatment
26. Suicide and schizophrenia: Clozapine and the InterSePT study
27. Characterization of schizophrenic patients who commit suicide
28. Depression, hopelessness and suicide in chronic schizophrenia
29. Risk factors for suicide among patients with schizophrenia
30. Factors predicting suicide in psychotic patients
31. Schizophrenics kill themselves too: A review of risk factors for suicide
32. Clozapine use by state programs: Public mental health systems respond to a new medication
33. Benchmarking treatment of schizophrenia: A comparison of service delivery by the national government and by state and local providers
34. Lithium treatment of depressed and non-depressed alcoholics
35. Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia